Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-3-2
pubmed:abstractText
To improve adherence and virologic suppression, we assessed the feasibility and effectiveness of a once-daily regimen of efavirenz with 3 nucleoside reverse transcriptase inhibitors as first-line or second-line highly active antiretroviral therapy in a cohort of HIV-1-infected children.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1098-4275
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
119
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e705-15
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17308244-Anti-HIV Agents, pubmed-meshheading:17308244-Antiretroviral Therapy, Highly Active, pubmed-meshheading:17308244-Benzoxazines, pubmed-meshheading:17308244-CD4 Lymphocyte Count, pubmed-meshheading:17308244-Child, pubmed-meshheading:17308244-Child, Preschool, pubmed-meshheading:17308244-Child Development, pubmed-meshheading:17308244-Cholesterol, pubmed-meshheading:17308244-Cohort Studies, pubmed-meshheading:17308244-Didanosine, pubmed-meshheading:17308244-Dideoxynucleosides, pubmed-meshheading:17308244-Dose-Response Relationship, Drug, pubmed-meshheading:17308244-Drug Administration Schedule, pubmed-meshheading:17308244-Drug Resistance, Viral, pubmed-meshheading:17308244-Female, pubmed-meshheading:17308244-Follow-Up Studies, pubmed-meshheading:17308244-HIV Infections, pubmed-meshheading:17308244-HIV-1, pubmed-meshheading:17308244-Humans, pubmed-meshheading:17308244-Infant, pubmed-meshheading:17308244-Lamivudine, pubmed-meshheading:17308244-Male, pubmed-meshheading:17308244-Oxazines, pubmed-meshheading:17308244-Patient Compliance, pubmed-meshheading:17308244-Prospective Studies, pubmed-meshheading:17308244-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
pubmed:affiliation
Emma Children's Hospital, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't